Ignite Creation Date:
2025-12-25 @ 1:04 AM
Ignite Modification Date:
2025-12-30 @ 2:57 PM
Study NCT ID:
NCT01441193
Status:
TERMINATED
Last Update Posted:
2016-03-04
First Post:
2011-09-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Proteins (ISS P-002)
Sponsor:
Barbara Ensoli, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-09
Start Date Type:
None
Primary Completion Date:
2014-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-02
Completion Date Type:
ACTUAL
First Submit Date:
2011-09-26
First Submit QC Date:
None
Study First Post Date:
2011-09-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-03-03
Last Update Post Date:
2016-03-04
Last Update Post Date Type:
ESTIMATED